Enliven Therapeutics Inc
XNAS: ELVN
Enliven Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product...
Read More
18.96
-0.96
(-4.82%)
2.3M
XNAS Volume
High volume today
XNAS 19 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Enliven Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..